Author:
Nerich Virginie,Fleck Camille,Chaigneau Loïc,Isambert Nicolas,Borg Christophe,Kalbacher Elsa,Jary Marine,Simon Pauline,Pivot Xavier,Blay Jean-Yves,Limat Samuel
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference45 articles.
1. Monges G, Bisot-Locard S, Blay JY, Bouvier AM, Urbieta M, Coindre JM, et al. The estimated incidence of gastrointestinal stromal tumors in France. Results of PROGIST conducted among pathologists. Bull Cancer. 2010;97(3):E16–22.
2. Blesius A, Cassier PA, Bertucci F, Fayette J, Ray-Coquard I, Bui B, et al. Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial. BMC Cancer. 2011;15:11–72.
3. Le Cesne A, Blay JY. Medical therapy of GIST: from palliative to curative treatment. Bull Acad Natl Med. 2012;196(4–5):861–74.
4. Dematteo RP, Heinrich MC, El-Rifai WM, Demetri G. Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol. 2002;33(5):466–77.
5. Van Oosterom AT, Judson I, Verweij J, Stroobants S, Donato di Paola E, Dimitrijevic S, et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet. 2001;358(9296):1903.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献